Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler®) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial

NEXThaler® is an effective and well-tolerated delivery device for treatment of patients with asthma who need a regular treatment.